REFERENCES
- Anglin M.D., Speckart. Narcotics Use and Crime: A Multisample Multimethods Analysis. Criminology 1988; 26: 197–233
- Anglin M.D., Hser Y.I. Addicted Women and Crime. Criminology 1987; 25: 359–397
- Ball J. Treatment Involvement and Outcome. Paper presented at Dutch-American Conference on the Effectiveness of Drug Abuse Treatment, Camden, NJUSA 1987
- Connell P.H. Review of Methadone Maintenance Schemes. Paper presented at Skandia International Symposia: Drug Dependence Treatment and Treatment Evaluation, Stockholm, Sweden 1975
- Cooper J.R. Methadone Treatment and Acquired Immunodeficiency Syndrome. JAMA 1989; 262(12)1664–1668
- Dole V.P., Joseph H. Long-term Outcome of Patients Treated with Methadone Maintenance. Ann NY Acad. Sci. 1978; 311: 181–189
- Dole V.P., Nyswander M.E., Warner A. Successful Treatment of 750 Criminal Addicts. JAMA 1968; 206(12)2708–2711
- Gearing F.R. Methadone Maintenance: Six Years Later. Contemp. Drug Prob. 1972; 1: 191–206
- Harwood H.J., Hubbard R.L., Collins J.J., Rachal J.V. The Costs of Crime and the Benefits of Drug Abuse Treatment: A Cost-Benefit Analysis Using TOPS Data. NIDA Res. Monogr. 1988; 86: 209–235
- Drug Abuse Treatment: A National Study of Effectiveness, R.L. Hubbard, M.E. Marsden, J.V. Rachal, H.J. Harwood, E.R. Cavanaugh, H.M. Ginzburg. University of North Carolina Press, Chapel Hill, NC 1989
- McLellan A.T., Luborsky L., O’Brien C.P., Woody G.E., Druley K.A. Is Treatment for Substance Abuse Effective?. JAMA 1982; 247(10)1423–1428
- Abdul-Quader A.S., Friedman S.R., Des Jarlais D.C., Marmor M.M., Maslansky R., Bartelme S. Methadone Maintenance and Behavior by Intravenous Drug Users That Can Transmit HIV. Contemp. Drug Prob. 1987; 425–434, Fall
- Simpson D.D. Treatment for Drug Abuse. Follow-up Outcomes and Length of Time Spent. Arch. Gen. Psychiatry 1981; 38(8)875–880
- Metzger D.S., Navaline H., Woody G.E. Drug Abuse Treatment as AIDS Prevention. Public Health Rep. 1998; 113: 97–106, Suppl 1
- Stark K., Müller R., Bienzle U., Guggenmoos-Holzmann I. Methadone Maintenance Treatment and HIV Risk-taking Behaviour Among Injecting Drug Users in Berlin. J. Epidemiol. Commun. Health 1996; 50(5)534–537
- Metzger D.S., Woody G.E., McLellan A.T., O’Brien C.P., Druley P., Navaline H., DePhilippis D., Stolley P., Abrutyn E. Human Immunodeficiency Virus Seroconversion Among Intravenous Drug Users In- and Out-of-Treatment: An 18-month Prospective Follow-up. J. Acquir. Immune Defic. Syndr. 1993; 6(9)1049–1056
- Serpelloni G., Carrieri M.P., Rezza G., Morganti S., Gomma M., Binkin N. Methadone Treatment as a Determinant of HIV Risk Reduction Among Injecting Drug Users: A Nested Case-control Study. AIDS Care 1994; 6(2)215–220
- Langendam M.W., van Brussel G.H., Coutinho R.A., van Ameijden E.J. The Impact of Harm-Reduction-Based Methadone Treatment on Mortality Among Heroin Users. Am. J. Public Health 2001; 91(5)774–780
- van Ameijden E.J., Langendam M.W., Coutinho R.A. Dose-effect Relationship Between Overdose Mortality and Prescribed Methadone Dosage in Low-threshold Maintenance Programs. Addict. Behav. 1994; 24(4)559–563
- Sees K.L., Delucchi K.L., Masson C., Rosen A., Clark H.W., Robillard H., Banys P., Hall S.M. Methadone Maintenance vs 180-day Psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial. JAMA 2000; 283(10)1303–1310
- Schutz C.G., Rapiti E., Vlahov D., Anthony J.C. Suspected Determinants of Enrollment Into Detoxification and Methadone Maintenance Treatment Among Injecting Drug Users. Drug Alcohol Depend. 1994; 36(2)129–138
- Shah N.G., Celentano D.D., Vlahov D., Stambolis V., Johnson L., Nelson K.E., Strathdee S.A. Correlates of Enrollment in Methadone Maintenance Treatment Programs Differ by HIV-serostatus. AIDS 2000; 14(13)2035–2043
- McCusker J., Willis G., McDonald M., Lewis B.F., Sereti S.M., Feldman Z.T. Admissions of Injection Drug Users to Drug Abuse Treatment Following HIV Counseling and Testing. Public Health Rep. 1994; 109(2)212–218
- Booth R.E., Crowley T.J., Zhang Y. Substance Abuse Treatment Entry, etention and Effectiveness: Out-of-Treatment Opiate Injection Drug Users. Drug Alcohol Depend 1996; 42(1)11–20
- Booth R.E., Kwiatkowski C., Iguchi M.Y., Pinto F., John D. Facilitating Treatment Entry Among Out-of-Treatment Injection Drug Users. Public Health Rep. 1998; 113: 116–128, Suppl 1(11)
- Zule W.A., Desmond D.P. Factors Predicting Entry of Injecting Drug Users Into Substance Abuse Treatment. Am. J. Drug Alcohol Abuse 2000; 26(2)247–261
- Heimer R., Kaplan E.H., O’Keefe E.O., Khoshnood K., Altice F. Three Years of Needle Exchange in New Haven: What Have We Learned?. AIDS Public Policy J. 1994; 9: 59–74
- Heimer R. Can Syringe Exchange Serve as a Conduit to Substance Abuse Treatment?. J. Subst. Abuse Treat. 1998; 15(3)183–191
- Brooner R., Kidorf M., King V., Beilenson P., Svikis D., Vlahov D. Drug Abuse Treatment Success Among Needle Exchange Participants. Public Health Rep. 1998; 113: 129–139, Suppl 1(8)
- Strathdee S.A., Celentano D.D., Shah N., Lyles C., Stambolis V.A., Macalino G., Nelson K., Vlahov D. Needle-exchange Attendance and Health Care Utilization Promote Entry Into Detoxification. J. Urban Health 1999; 76(4)448–460
- Hagan H., McGough J.P., Thiede H., Hopkins S., Duchin J., Alexander E.R. Reduced Injection Frequency and Increased Entry and Retention in Drug Treatment Associated with Needle-Exchange Participation in Seattle Drug Injectors. J. Subst. Abuse Treat. 2000; 19(3)247–252
- Yoast R., Williams M.A., Deitchman S.D., Champion H.C. Report of the Council on Scientific Affairs: Methadone Maintenance and Needle-exchange Programs to Reduce the Medical and Public Health Consequences of Drug Abuse. J. Addict. Dis. 2001; 20(2)15–40
- Vlahov D., Junge B., Brookmeyer R., Cohn S., Riley E., Armenian H., Beilenson P. Reductions in High-risk Drug Use Behaviors Among Participants in the Baltimore Needle Exchange Program. J. Acqr. Immune Defic. Syndr. Human Retrovirol. 1997; 16(5)400–406